Evidence map›Paper›PMID 19436703›Full record

ArticlePLoS medicine2009

Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease.

Kittipong Maneechotesuwan, Xin Yao, Kazuhiro Ito, Elen Jazrawi, Omar S Usmani, Ian M Adcock, Peter J Barnes

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Article
  3. Stress induces corticosterone-mediated CD8Cancer immunology, immunotherapy : CII · 2025
    Article
  4. Mechanisms and Therapeutic Implications of EZH2 in Nasal Diseases.Clinical reviews in allergy & immunology · 2025
    Review
  5. Heat Stress Influences Immunity ThroughAnimals : an open access journal from MDPI · 2025
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Corticosteroids for COVID-19.Journal of intensive medicine · 2021
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kittipong ManeechotesuwanAirway Disease Section, National Heart and Lung Institute, Imperial College, London, United Kingdom.
Xin Yao
Kazuhiro Ito
Elen Jazrawi
Omar S Usmani
Ian M Adcock
Peter J Barnes
Imperial College London · GB

Funding

Medical Research Council G0801266
6 · The paper itself

Abstract

backgroundGATA-3 plays a critical role in regulating the expression of the cytokines interleukin (IL)-4, IL-5, and IL-13 from T helper-2 (Th2) cells and therefore is a key mediator of allergic diseases. Corticosteroids are highly effective in suppressing allergic inflammation, but their effects on GATA-3 are unknown. We investigated the effect of the corticosteroid fluticasone propionate on GATA-3 regulation in human T-lymphocytes in vitro and in vivo. METHODS AND

findingsIn a T lymphocyte cell line (HuT-78) and peripheral blood mononuclear cells stimulated by anti-CD3 and anti-CD28 in vitro we demonstrated that fluticasone inhibits nuclear translocation of GATA-3 and expression of Th2 cytokines via a mechanism independent of nuclear factor-kappaB and is due, in part, to competition between GATA-3 and the ligand-activated glucocorticoid receptor for nuclear transport through the nuclear importer importin-alpha. In addition, fluticasone induces the expression of mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1), the endogenous inhibitor of p38 MAPK, which is necessary for GATA-3 nuclear translocation. These inhibitory effects of fluticasone are rapid, potent, and prolonged. We also demonstrated that inhaled fluticasone inhibits GATA-3 nuclear translocation in peripheral blood lymphocytes of patients with asthma in vivo.

conclusionsCorticosteroids have a potent inhibitory effect on GATA-3 via two interacting mechanisms that potently suppress Th2 cytokine expression. This novel mechanism of action of corticosteroids may account for the striking clinical efficacy of corticosteroids in the treatment of allergic diseases.

Indexed as

Active Transport, Cell NucleusAdministration, InhalationAdrenal Cortex Hormonesalpha KaryopherinsAndrostadienesAnti-Allergic AgentsAsthmaCell LineCytokinesDual Specificity Phosphatase 1FluticasoneGATA3 Transcription FactorGene Expression RegulationHumansHypersensitivityInterleukin-4Adrenal Cortex Hormonesalpha KaryopherinsAndrostadienesAnti-Allergic AgentsCytokinesDual Specificity Phosphatase 1FluticasoneGATA3 Transcription FactorInterleukin-4Receptors, Glucocorticoid

Identifiers

PMID19436703
PMCPMC2674207
OpenAlexW2028519409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.